Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 06:00:02 05/09/26 am AEST			5-day change	1st Jan Change
386.11 ^USD	-0.46%		-0.41%	+27.43%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	10.22B	BBB	-
ABBOTT LABORATORIES	187B	BBB
MEDTRONIC PLC	120B	BBB
CENCORA, INC.	63.15B	AA
HOYA CORPORATION	51.75B	AAA
BECTON, DICKINSON AND COMPANY	50.32B	A
DEXCOM, INC.	33.17B	BBB
MEDLINE INC.	32.1B	A
WEST PHARMACEUTICAL SERVICES, INC.	23.93B	AA
TERUMO CORPORATION	22.99B	AA
SARTORIUS STEDIM BIOTECH	21.52B	BBB
STERIS PLC	21.9B	AAA	-
ZIMMER BIOMET HOLDINGS, INC.	18.71B	A
SOLVENTUM CORPORATION	15.61B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.51B	A
BAXTER INTERNATIONAL INC.	13.35B	A
ALIGN TECHNOLOGY, INC.	11.27B	A
GLOBUS MEDICAL, INC.	10.51B	CCC
INSULET CORPORATION	10.23B	A
AVANTOR, INC.	10.13B	AA
Average	37.21B	A
Weighted average by Cap.		A